Skip to main content
Erschienen in: Familial Cancer 2/2010

01.06.2010

Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families

verfasst von: J. M. Chiang, H. W. Chen, R. P. Tang, J. S. Chen, C. R. Changchien, P. S. Hsieh, J. Y. Wang

Erschienen in: Familial Cancer | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Familial adenomatous polyposis (FAP) is an autosomal-dominant disease caused by germline mutations in the adenomatous polyposis coli (APC) gene. The affected individuals develop colorectal polyposis and show various extra-colonic manifestations. In this study, we aimed to investigate the genetic and clinical characteristics of FAP in Taiwanese families and analyze the genotype–phenotype correlations. Blood samples were obtained from 66 FAP patients registered in the hereditary colorectal cancer database. Then, germline mutations in the APC genes of these 66 polyposis patients from 47 unrelated FAP families were analyzed. The germline-mutation-negative cases were analyzed by performing multiplex ligation-dependent probe amplification (MLPA) and single-strand conformation polymorphism (SSCP) analysis of the MUTYH gene. Among the analyzed families, 79% (37/47) of the families showed 28 APC mutations, including 19 frameshift mutations, 4 nonsense mutations, 3 genomic deletion mutations, 1 missense mutation, and 1 splice-site mutation. In addition, we identified 15 novel mutations in 32% (15/47) of the families. The cases in which APC mutations were not identified showed significantly lower incidence of profuse polyposis (P = 0.034) and gastroduodenal polyps (P = 0.027). Furthermore, FAP families in which some affected individuals had less than 100 polyps showed significant association with low incidence of APC germline mutations (P = 0.002). We have added the APC germline-mutation data for Taiwanese FAP patients and indicated the presence of an FAP subgroup comprising affected individuals with nonadenomatous polyps or less than 100 adenomatous polyps; this form of FAP is less frequently caused by germline mutations of the APC gene.
Literatur
1.
Zurück zum Zitat Kinzler KW, Nilbert MC, Vogelstein B et al (1991) Identification of FAP locus genes from chromosomes 5q21. Science 253:661–664CrossRefPubMed Kinzler KW, Nilbert MC, Vogelstein B et al (1991) Identification of FAP locus genes from chromosomes 5q21. Science 253:661–664CrossRefPubMed
2.
Zurück zum Zitat Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis gene. Cell 66:589–600CrossRefPubMed Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis gene. Cell 66:589–600CrossRefPubMed
3.
Zurück zum Zitat Su L-K, Kohlmann W, Ward PA et al (2002) Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15. Hum Genet 111:88–95CrossRefPubMed Su L-K, Kohlmann W, Ward PA et al (2002) Different familial adenomatous polyposis phenotypes resulting from deletions of the entire APC exon 15. Hum Genet 111:88–95CrossRefPubMed
4.
Zurück zum Zitat Michils G, Tejpar S, Thoelen R et al (2005) Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutation 25:125–134CrossRef Michils G, Tejpar S, Thoelen R et al (2005) Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutation 25:125–134CrossRef
5.
Zurück zum Zitat Flintoff KJ, Sheridan E, Turner G, Chu CE, Taylor GR (2001) Submicroscopic deletions of the APC gene: a frequent cause of familial adenomatous olyposis that may be overlooked by conventional mutation scanning. J Med Genet 38:129–132CrossRefPubMed Flintoff KJ, Sheridan E, Turner G, Chu CE, Taylor GR (2001) Submicroscopic deletions of the APC gene: a frequent cause of familial adenomatous olyposis that may be overlooked by conventional mutation scanning. J Med Genet 38:129–132CrossRefPubMed
6.
Zurück zum Zitat Sieber OM, Lamlum H, Crabtree MD et al (2002) Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple colorectal adenomas”. Proc Natl Acad Sci USA 99:2954–2958CrossRefPubMed Sieber OM, Lamlum H, Crabtree MD et al (2002) Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or “multiple colorectal adenomas”. Proc Natl Acad Sci USA 99:2954–2958CrossRefPubMed
7.
Zurück zum Zitat Bunyan DJ, Eccles DM, Silibourme J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159CrossRefPubMed Bunyan DJ, Eccles DM, Silibourme J et al (2004) Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer 91:1155–1159CrossRefPubMed
8.
Zurück zum Zitat Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mut 23:413–419CrossRefPubMed Sellner LN, Taylor GR (2004) MLPA and MAPH: new techniques for detection of gene deletions. Hum Mut 23:413–419CrossRefPubMed
9.
Zurück zum Zitat Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeiutic decisions in familial adenomatous polyposis? experience from 680 FAP families. Gut 48:515–521CrossRefPubMed Friedl W, Caspari R, Sengteller M et al (2001) Can APC mutation analysis contribute to therapeiutic decisions in familial adenomatous polyposis? experience from 680 FAP families. Gut 48:515–521CrossRefPubMed
10.
Zurück zum Zitat Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMed Miyaki M, Konishi M, Kikuchi-Yanoshita R et al (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020PubMed
11.
Zurück zum Zitat Moisio A-L, Jarvinen H, Peltomaki P (2002) Genetic and clinical characterization of familial adenomatous polyposis: a population based study. Gut 50:845–850CrossRefPubMed Moisio A-L, Jarvinen H, Peltomaki P (2002) Genetic and clinical characterization of familial adenomatous polyposis: a population based study. Gut 50:845–850CrossRefPubMed
12.
Zurück zum Zitat Mandl M, Paffenholz R, Friedl W et al (1994) Frequency of common and novel inactivationg APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet 3:181–184CrossRefPubMed Mandl M, Paffenholz R, Friedl W et al (1994) Frequency of common and novel inactivationg APC mutations in 202 families with familial adenomatous polyposis. Hum Mol Genet 3:181–184CrossRefPubMed
13.
Zurück zum Zitat Crabtree MD, Tomlinson IPM, Hodgson SV, Neale K, Phillips RKS (2002) Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 51:420–423CrossRefPubMed Crabtree MD, Tomlinson IPM, Hodgson SV, Neale K, Phillips RKS (2002) Explaining variation in familial adenomatous polyposis: relationship between genotype and phenotype and evidence for modifier genes. Gut 51:420–423CrossRefPubMed
14.
Zurück zum Zitat Bisgaard ML, Ripa R, Knudsen AL, Bulow S (2004) Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53:266–270CrossRefPubMed Bisgaard ML, Ripa R, Knudsen AL, Bulow S (2004) Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype. Gut 53:266–270CrossRefPubMed
15.
Zurück zum Zitat Heinimann K, Mullhaupt B, Weber W et al (1998) Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 43:675–679PubMedCrossRef Heinimann K, Mullhaupt B, Weber W et al (1998) Phenotypic differences in familial adenomatous polyposis based on APC gene mutation status. Gut 43:675–679PubMedCrossRef
16.
Zurück zum Zitat Kairupan CF, Meldrum CJ, Crooks R, Milward EA, Spegelman AD, Burgess B (2005) Mutation analysis of the MYH gene in an Australian series of colorectal Polyposis patients with or without germline APC mutations. Int J Cancer 116:73–77CrossRefPubMed Kairupan CF, Meldrum CJ, Crooks R, Milward EA, Spegelman AD, Burgess B (2005) Mutation analysis of the MYH gene in an Australian series of colorectal Polyposis patients with or without germline APC mutations. Int J Cancer 116:73–77CrossRefPubMed
17.
Zurück zum Zitat Prosser J, Condie A, Wright M et al (1994) APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 70:841–846PubMed Prosser J, Condie A, Wright M et al (1994) APC mutation analysis by chemical cleavage of mismatch and a protein truncation assay in familial adenomatous polyposis. Br J Cancer 70:841–846PubMed
18.
Zurück zum Zitat Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMed Miyoshi Y, Ando H, Nagase H et al (1992) Germ-line mutations of APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 89:4452–4456CrossRefPubMed
19.
Zurück zum Zitat Stella A, Resta N, Gentile M, Susca F, Mareni C, Montera MP, Guanti G (1993) Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 53:1031–1037PubMed Stella A, Resta N, Gentile M, Susca F, Mareni C, Montera MP, Guanti G (1993) Exclusion of the APC gene as the cause of a variant form of familial adenomatous polyposis (FAP). Am J Hum Genet 53:1031–1037PubMed
20.
Zurück zum Zitat Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalier J, Howard L, Burt R, White R, Leppert M (1992) Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMed Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalier J, Howard L, Burt R, White R, Leppert M (1992) Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92–100PubMed
21.
Zurück zum Zitat Cao X, Eu KW, Seow-Choen F, Zao Y, Cheah PY (2000) APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8:42–48CrossRefPubMed Cao X, Eu KW, Seow-Choen F, Zao Y, Cheah PY (2000) APC mutation and phenotypic spectrum of Singapore familial adenomatous polyposis patients. Eur J Hum Genet 8:42–48CrossRefPubMed
22.
Zurück zum Zitat Kim DW, Kim IJ, Kang HC et al (2005) Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 26:281CrossRefPubMed Kim DW, Kim IJ, Kang HC et al (2005) Mutation spectrum of the APC gene in 83 Korean FAP families. Hum Mutat 26:281CrossRefPubMed
23.
Zurück zum Zitat Scott RJ, Meldrum C, Crooks R et al (2001) Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut 48:508–514CrossRefPubMed Scott RJ, Meldrum C, Crooks R et al (2001) Familial adenomatous polyposis: more evidence for disease diversity and genetic heterogeneity. Gut 48:508–514CrossRefPubMed
24.
Zurück zum Zitat Giardiello FM, Krush AJ, Petersen GM et al (1994) Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 106:1542–1547PubMed Giardiello FM, Krush AJ, Petersen GM et al (1994) Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 106:1542–1547PubMed
25.
Zurück zum Zitat Ruiz-Ponte C, Vega A, Carracedo A, Barros F (2001) Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum Mutat 18:355CrossRefPubMed Ruiz-Ponte C, Vega A, Carracedo A, Barros F (2001) Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer. Hum Mutat 18:355CrossRefPubMed
26.
Zurück zum Zitat Aretz S, Uhlhaas S, Caspari R et al (2004) Frequency and parenteral origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMed Aretz S, Uhlhaas S, Caspari R et al (2004) Frequency and parenteral origin of de novo APC mutations in familial adenomatous polyposis. Eur J Hum Genet 12:52–58CrossRefPubMed
27.
Zurück zum Zitat Ripa R, Bisgaard ML, Bulow S, Nielsen FC (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10:887–888CrossRef Ripa R, Bisgaard ML, Bulow S, Nielsen FC (2002) De novo mutations in familial adenomatous polyposis (FAP). Eur J Hum Genet 10:887–888CrossRef
Metadaten
Titel
Mutation analysis of the APC gene in Taiwanese FAP families: low incidence of APC germline mutation in a distinct subgroup of FAP families
verfasst von
J. M. Chiang
H. W. Chen
R. P. Tang
J. S. Chen
C. R. Changchien
P. S. Hsieh
J. Y. Wang
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 2/2010
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-009-9292-2

Weitere Artikel der Ausgabe 2/2010

Familial Cancer 2/2010 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.